Details

Last Funding Type

Post-IPO Debt

Last Funding Money Raised

$5M

Industries

Biotechnology,Genetics,Health Care,Medical

Founded date

Jan 1, 1997

Number Of Employee

1 - 10

Operating Status

Close

Stock Symbol

otcqb:ILIU

Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.

Interleukin Genetics has acquired 1 organizations. Their most recent acquisition was Alan James Group on Aug 17, 2006. They acquired Alan James Group for 0.

Date Company Name	Industry	Acquisition Type	Price
Aug 17, 2006 Alan James Group	Consumer Goods	—	—	Detail